Cargando…

Immune checkpoint inhibitor–induced diabetes mellitus with pembrolizumab

An 81-year-old woman with a background of metastatic melanoma on pembrolizumab with no history of diabetes was brought into the emergency department with polyuria, polydipsia and weight loss. The initial assessment was consistent with severe diabetic ketoacidosis (DKA) and prerenal acute kidney inju...

Descripción completa

Detalles Bibliográficos
Autores principales: Zand Irani, Anis, Almuwais, Ahmed, Gibbons, Holly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8768469/
https://www.ncbi.nlm.nih.gov/pubmed/35039353
http://dx.doi.org/10.1136/bcr-2021-245846